Straits Times Index
3,240.58 +49.87 (+1.56%) Nikkei
26,739.03 +336.19 (+1.27%) Hang Seng
20,717.24 +596.56 (+2.96%) FTSE 100
7,389.98 +87.24 (+1.19%) BTC-USD
28,888.93 -1,161.73 (-3.87%) CMC Crypto 200
643.81 -29.57 (-4.39%)
Cybin Inc. (CYBN)
| Previous close | 0.5700 |
| Open | 0.5778 |
| Bid | 0.5800 x 1300 |
| Ask | 0.5860 x 1100 |
| Day's range | 0.5801 - 0.6084 |
| 52-week range | 0.3900 - 3.3800 |
| Volume | |
| Avg. volume | 720,764 |
| Market cap | 95.648M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2940 |
| Earnings date | 10 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.00 |
- Business Wire
Cybin to Participate in NYSE Trading Bell Ceremony on May 18, 2022
TORONTO, May 17, 2022--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (Cybin or the Company), a biopharmaceutical company focused on progressing "Psychedelics to TherapeuticsTM" is pleased to announce that it will participate in the morning trading bell ceremony on May 18, 2022 at the New York Stock Exchange ("NYSE") in New York City.
- Business Wire
Cybin to Present at the H.C. Wainwright Global Investment Conference on May 25, 2022
TORONTO, May 11, 2022--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin" or the "Company"), a biopharmaceutical company focused on progressing "Psychedelics to TherapeuticsTM" is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright Global Investment Hybrid Conference being held at the Fontainebleau Miami Beach May 23-26, 2022.
- Business Wire
Cybin and Kernel Announce Results from Kernel Flow® Piloting of Feasibility Study Measuring Ketamine’s Effects on the Brain
LOS ANGELES & TORONTO, May 09, 2022--Cybin and Kernel Announce Results from Kernel Flow® Piloting of Feasibility Study Measuring Ketamine’s Effects on the Brain
